Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Masashi Ninomiya"'
Autor:
Masashi Ninomiya, Mio Tsuruoka, Jun Inoue, Atsushi Hiraoka, Tomoaki Iwata, Akitoshi Sano, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Fujita, Kazumichi Abe, Tomohiro Katsumi, Wataru Sato, Go Igarashi, Chikara Iino, Tetsu Endo, Nobukazu Tanabe, Hiroshi Numao, Katsunori Iijima, Takayuki Matsumoto, Hiromasa Ohira, Yoshiyuki Ueno, Atsushi Masamune
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract It is difficult to determine whether an individual therapy contributes to the elongation of survival because of the difficulty of organizing clinical research in patients who receive multiple treatments in HCC. We aimed to establish a new mo
Externí odkaz:
https://doaj.org/article/11d8cecf2b5d4cb8a1e0c970a7172a60
Autor:
Masashi Fujita, Kazumichi Abe, Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, Atsushi Masamune, Kazuo Okumoto, Tomohiro Katsumi, Wataru Sato, Katsunori Iijima, Tetsu Endo, Shinsaku Fukuda, Nobukazu Tanabe, Hiroshi Numao, Yasuhiro Takikawa, Yoshiyuki Ueno, Hiromasa Ohira
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Sarcopenia is associated with poor prognosis of patients with hepatocellular carcinoma (HCC). We investigated the association of skeletal muscle volume (SMV) and its change in HCC patients taking lenvatinib. In 130 HCC patients, psoas mass i
Externí odkaz:
https://doaj.org/article/90a8f11b5c724eb5964b2dfc5f11d103
Autor:
Masashi Ninomiya, Jun Inoue, Eugene W. Krueger, Jing Chen, Hong Cao, Atsushi Masamune, Mark A. McNiven
Publikováno v:
Hepatology Communications, Vol 5, Iss 7, Pp 1238-1251 (2021)
Currently, the hepatocellular trafficking pathways that are used by the hepatitis B virus (HBV) during viral infection and shedding are poorly defined. It is known that the HBV uses late endosomal and multivesicular body (MVB) compartments for assemb
Externí odkaz:
https://doaj.org/article/412340d7d6034a27bfd3e8616f084bbf
Autor:
Akitoshi Sano, Jun Inoue, Eiji Kakazu, Masashi Ninomiya, Mio Tsuruoka, Kosuke Sato, Masazumi Onuki, Satoko Sawahashi, Keishi Ouchi, Atsushi Masamune
Publikováno v:
Journal of Clinical & Translational Hepatology; Jul2024, Vol. 12 Issue 7, p613-624, 12p
Autor:
Mio Tsuruoka, Jun Inoue, Yasushi Onishi, Masashi Ninomiya, Eiji Kakazu, Tomoaki Iwata, Akitoshi Sano, Kosuke Sato, Hideo Harigae, Atsushi Masamune
Publikováno v:
Case Reports in Gastroenterology, Vol 15, Iss 1, Pp 178-187 (2021)
Reactivation of hepatitis B virus (HBV) is known to occur frequently after hematopoietic stem cell transplantation (HSCT). The reactivation can be prevented by nucleos(t)ide analogue (NA), but it is unclear how long NA should be continued. Here, we r
Externí odkaz:
https://doaj.org/article/523c3610328d470b97cabae8bc6b3ebf
Autor:
Hidekatsu Kuroda, Takayoshi Oikawa, Masashi Ninomiya, Masashi Fujita, Kazumichi Abe, Kazuo Okumoto, Tomohiro Katsumi, Wataru Sato, Go Igarashi, Chikara Iino, Tetsu Endo, Nobukazu Tanabe, Hiroshi Numao, Shinsaku Fukuda, Katsunori Iijima, Atsushi Masamune, Hiromasa Ohira, Yoshiyuki Ueno, Yasuhiro Takikawa
Publikováno v:
Liver Cancer (2022)
Objective: There is limited information regarding the benefits of Lenvatinib-transcatheter arterial chemoembolization (LEN-TACE) sequential therapy for unresectable hepatocellular carcinoma (u-HCC). We compared the efficacy and safety of LEN-TACE seq
Externí odkaz:
https://doaj.org/article/6a9871223fd94efcbd3d56089fd44d0f
Duodenal Variceal Rupture during Atezolizumab and Bevacizumab Treatment for Hepatocellular Carcinoma
Autor:
Mio, Tsuruoka, Jun, Inoue, Keishi, Ouchi, Kaname, Uno, Hideaki, Itami, Masashi, Ninomiya, Tomoaki, Iwata, Akitoshi, Sano, Kosuke, Sato, Masazumi, Onuki, Satoko, Sawahashi, Tomoyuki, Koike, Atsushi, Masamune
Publikováno v:
Internal Medicine. 62:1467-1472
Duodenal varices are detected infrequently, and their rupture is very rare. We encountered an 87-year-old man who developed duodenal varices rupture during chemotherapy with atezolizumab and bevacizumab (ATZ/BV) for hepatocellular carcinoma. We ident
Autor:
Akihiro Saito, Masafumi Kikuchi, Yuko Matsumoto, Erina Sugawara, Gesshu Takao, Hayato Inomata, Akane Takahashi, Yuji Sato, Masaki Kumondai, Yu Sato, Toshihiro Sato, Masashi Ninomiya, Jun Inoue, Masamitsu Maekawa, Nariyasu Mano
Publikováno v:
Therapeutic Drug Monitoring. 44:771-776
The anticancer drug, Lenvima (lenvatinib), has severe side effects. Therapeutic drug monitoring helps ensure its efficacy and safety. Regular and optimally timed blood sampling is tough, especially when lenvatinib is self-medicated. Microsampling usi
Autor:
Teruyuki Umetsu, Jun Inoue, Takayuki Kogure, Eiji Kakazu, Masashi Ninomiya, Tomoaki Iwata, Satoshi Takai, Takuya Nakamura, Akitoshi Sano, Tooru Shimosegawa
Publikováno v:
Biochemistry and Biophysics Reports, Vol 14, Iss C, Pp 20-25 (2018)
Hepatitis B virus (HBV) infection is a worldwide health problem because of its potential to cause liver cirrhosis and hepatocellular carcinoma. Silibinin is a constituent of an extract of milk thistle, which is empirically used as a herbal medicine f
Externí odkaz:
https://doaj.org/article/662045a3440f4198b3d3330f095606f8
Publikováno v:
Viruses, Vol 13, Iss 6, p 1124 (2021)
The envelope of hepatitis B virus (HBV), which is required for the entry to hepatocytes, consists of a lipid bilayer derived from hepatocyte and HBV envelope proteins, large/middle/small hepatitis B surface antigen (L/M/SHBs). The mechanisms and host
Externí odkaz:
https://doaj.org/article/9013126578b640b4a1fe1eb9c0d4eaf7